Menu Search
Equities

Mabpharm Ltd

2181:HKG

Mabpharm Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)0.305
  • Today's Change0.00 / 0.00%
  • Shares traded40.00k
  • 1 Year change-37.11%
  • Beta0.6697
Data delayed at least 15 minutes, as of Sep 13 2024 03:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in CNYView more

In 2023, Mabpharm Ltd increased its cash reserves by 416.40%, or 139.78m. Cash Flow from Financing totalled 85.60m or 98.21% of revenues. In addition the company generated 57.39m in cash from operations while cash used for investing totalled 3.51m.
Cash flow per share-0.0381
Price/Cash flow per share--
Book value per share0.0307
Tangible book value per share0.0307
More ▼

Balance sheet in CNYView more

Mabpharm Ltd has a Debt to Total Capital ratio of 67.90%, a higher figure than the previous year's 27.29%.
Current ratio1.07
Quick ratio0.6836
Total debt/total equity2.12
Total debt/total capital0.679
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.